Cargando…
Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey
The early attainment of high COVID-19 vaccination rates can minimize avoidable hospitalizations/deaths. The fifth wave COVID-19 outbreak in Hong Kong caused >9000 deaths, and most of them were unvaccinated older people. This study hence investigated determinants of taking the first dose vaccinati...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304556/ https://www.ncbi.nlm.nih.gov/pubmed/37376418 http://dx.doi.org/10.3390/vaccines11061029 |
_version_ | 1785065538285731840 |
---|---|
author | Yu, Yanqiu Yen, Stefanie Hoi Ying Jiang, Li Crystal Ming, Wai-kit Lau, Mason M. C. Lau, Joseph T. F. |
author_facet | Yu, Yanqiu Yen, Stefanie Hoi Ying Jiang, Li Crystal Ming, Wai-kit Lau, Mason M. C. Lau, Joseph T. F. |
author_sort | Yu, Yanqiu |
collection | PubMed |
description | The early attainment of high COVID-19 vaccination rates can minimize avoidable hospitalizations/deaths. The fifth wave COVID-19 outbreak in Hong Kong caused >9000 deaths, and most of them were unvaccinated older people. This study hence investigated determinants of taking the first dose vaccination at a later phase (Phase 3: during the fifth wave outbreak, i.e., February–July 2022) versus two earlier phases (Phase 1: first six months since vaccine rollout, i.e., February–July 2021; Phase 2: six months prior to the outbreak, i.e., August 2021–January 2022) via a random telephone survey among 386 ever-vaccinated Hong Kong older people aged ≥60 (June/July 2022). A total of 27.7%, 51.1%, and 21.3% took the first dose at Phase 1, Phase 2, and Phase 3, respectively. Unfavorable perceptions related to COVID-19/vaccination, exposure to conflicting/counter-information about the suitability of older people’s vaccination from various sources, unsupportive family influences prior to the outbreak, and depressive symptoms were significantly associated with taking the first dose at Phase 3 instead of Phase 1 and Phase 2. To speed up COVID-19 vaccination and avoid unnecessary deaths, the government and health professionals should rectify misinformation, provide clear/consistent information for older people and their family members, and focus on those having depressive symptoms at an earlier stage of the pandemic. |
format | Online Article Text |
id | pubmed-10304556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-103045562023-06-29 Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey Yu, Yanqiu Yen, Stefanie Hoi Ying Jiang, Li Crystal Ming, Wai-kit Lau, Mason M. C. Lau, Joseph T. F. Vaccines (Basel) Article The early attainment of high COVID-19 vaccination rates can minimize avoidable hospitalizations/deaths. The fifth wave COVID-19 outbreak in Hong Kong caused >9000 deaths, and most of them were unvaccinated older people. This study hence investigated determinants of taking the first dose vaccination at a later phase (Phase 3: during the fifth wave outbreak, i.e., February–July 2022) versus two earlier phases (Phase 1: first six months since vaccine rollout, i.e., February–July 2021; Phase 2: six months prior to the outbreak, i.e., August 2021–January 2022) via a random telephone survey among 386 ever-vaccinated Hong Kong older people aged ≥60 (June/July 2022). A total of 27.7%, 51.1%, and 21.3% took the first dose at Phase 1, Phase 2, and Phase 3, respectively. Unfavorable perceptions related to COVID-19/vaccination, exposure to conflicting/counter-information about the suitability of older people’s vaccination from various sources, unsupportive family influences prior to the outbreak, and depressive symptoms were significantly associated with taking the first dose at Phase 3 instead of Phase 1 and Phase 2. To speed up COVID-19 vaccination and avoid unnecessary deaths, the government and health professionals should rectify misinformation, provide clear/consistent information for older people and their family members, and focus on those having depressive symptoms at an earlier stage of the pandemic. MDPI 2023-05-26 /pmc/articles/PMC10304556/ /pubmed/37376418 http://dx.doi.org/10.3390/vaccines11061029 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yu, Yanqiu Yen, Stefanie Hoi Ying Jiang, Li Crystal Ming, Wai-kit Lau, Mason M. C. Lau, Joseph T. F. Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title | Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title_full | Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title_fullStr | Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title_full_unstemmed | Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title_short | Levels and Determinants of COVID-19 Vaccination at a Later Phase among Chinese Older People Aged 60 Years or Older: A Population-Based Survey |
title_sort | levels and determinants of covid-19 vaccination at a later phase among chinese older people aged 60 years or older: a population-based survey |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304556/ https://www.ncbi.nlm.nih.gov/pubmed/37376418 http://dx.doi.org/10.3390/vaccines11061029 |
work_keys_str_mv | AT yuyanqiu levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey AT yenstefaniehoiying levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey AT jianglicrystal levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey AT mingwaikit levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey AT laumasonmc levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey AT laujosephtf levelsanddeterminantsofcovid19vaccinationatalaterphaseamongchineseolderpeopleaged60yearsorolderapopulationbasedsurvey |